RIGH: BG Medical Technologies Upgraded to “Current” Status by OTC Markets
Jul 07, 2014
OTC Disclosure & News Service
http://www.otcmarkets.com/stock/RIGH/news/BG-...s?id=84011
BG Medical Technologies, Inc. (OTC: RIGH) has by now been upgraded by OTC Markets to OTC Markets Current reporting status. OTC Markets is now providing quotes by listing full information for the company.
“Our focus is on the long-term growth of our business. By popular demand of our shareholders, who are partners and co-owners of the company, we will continue to enhance public communication by now increasing transparency. We are committed to voluntarily submitting these reports on an ongoing basis,” stated CEO Angel Stanz.
Shareholders have now expressed that by these efforts the company could grow shareholder value and increase the company’s base of prospective business contacts.
“We are not here to generate a quick buck, but rather to introduce a get rich slowly plan. Our business model presents a great way to grow with medical cannabis opportunities on a strong and steady path. Our true partners are our buy-and-hold investors. While our upgraded reporting status may be beneficial for day traders, we want to be clear that we are holding to our long term commitments by serving the needs of our true shareholders through building business and by growing the company.”
BG Medical Technologies and BudGenius.com are established medical marijuana brands, serving the industry since 2010 by cannabis laboratory analysis and by Internet technology related services.
About BG Medical Technologies
BG Medical Technologies is a medical marijuana company that develops technology and research software for cannabis and natural health solutions. The Company collects data through a network of proprietary software, utilized by patients, by retail operators, and by medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform connecting cannabis patients to regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for cannabis study, utilized to determine potency and safety guidance for patients and medicine manufacturers.
For more information please visit:
http://www.BudGenius.com
http://www.BgMedTech.com
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Copyright © 2014 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Jul 07, 2014
OTC Disclosure & News Service
http://www.otcmarkets.com/stock/RIGH/news/BG-...s?id=84011
BG Medical Technologies, Inc. (OTC: RIGH) has by now been upgraded by OTC Markets to OTC Markets Current reporting status. OTC Markets is now providing quotes by listing full information for the company.
“Our focus is on the long-term growth of our business. By popular demand of our shareholders, who are partners and co-owners of the company, we will continue to enhance public communication by now increasing transparency. We are committed to voluntarily submitting these reports on an ongoing basis,” stated CEO Angel Stanz.
Shareholders have now expressed that by these efforts the company could grow shareholder value and increase the company’s base of prospective business contacts.
“We are not here to generate a quick buck, but rather to introduce a get rich slowly plan. Our business model presents a great way to grow with medical cannabis opportunities on a strong and steady path. Our true partners are our buy-and-hold investors. While our upgraded reporting status may be beneficial for day traders, we want to be clear that we are holding to our long term commitments by serving the needs of our true shareholders through building business and by growing the company.”
BG Medical Technologies and BudGenius.com are established medical marijuana brands, serving the industry since 2010 by cannabis laboratory analysis and by Internet technology related services.
About BG Medical Technologies
BG Medical Technologies is a medical marijuana company that develops technology and research software for cannabis and natural health solutions. The Company collects data through a network of proprietary software, utilized by patients, by retail operators, and by medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform connecting cannabis patients to regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for cannabis study, utilized to determine potency and safety guidance for patients and medicine manufacturers.
For more information please visit:
http://www.BudGenius.com
http://www.BgMedTech.com
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Copyright © 2014 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
